Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

2(33.3%)

Phase 2

2(33.3%)

N/A

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 1(2)

Phase 2(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07544550Not ApplicableNot Yet Recruiting

Rocking Chairs as Post-operative Treatment for Older Adults After Hip Surgery

Role: collaborator

NCT01064765Completed

ACT-HF: Attention, Cognition and Self-Management in Heart Failure

Role: collaborator

NCT00555841Phase 2Terminated

Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue

Role: lead

NCT00399919Phase 3Completed

Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

Role: lead

NCT00032903Phase 1Completed

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

Role: lead

NCT00033202Phase 1Completed

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor

Role: lead

NCT00225160Phase 2Unknown

ALCAR Prophylaxis Study

Role: collaborator

All 7 trials loaded